Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain

<div>Platelet count and romiplostim dose evolution: (a) case 1: newly diagnosed ITP; (b) case 2: persistent ITP; (c) case 3: chronic ITP; splenectomized; (d) case 4: chronic ITP; nonsplenectomized.</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain 

Figure 1 | Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain 